Literature DB >> 12835324

The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor.

Annette Lasham1, Stephanie Moloney, Tracy Hale, Craig Homer, You Fang Zhang, J Greg Murison, Antony W Braithwaite, James Watson.   

Abstract

The p53 tumor suppressor plays a major role in preventing tumor development by transactivating genes to remove or repair potentially tumorigenic cells. Here we show that the Y-box-binding protein, YB1, acts as a negative regulator of p53. Using reporter assays we show that YB1 represses transcription of the p53 promoter in a sequence-specific manner. We also show that YB1 reduces endogenous levels of p53, which in turn reduces p53 activity. Conversely, inhibiting YB1 in a variety of tumor cell lines induces p53 activity, resulting in significant apoptosis via a p53-dependent pathway. These data suggest that YB1 may, in some situations, protect cells from p53-mediated apoptosis, indicating that YB1 may be a good target for the development of new therapeutics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835324     DOI: 10.1074/jbc.M303920200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Authors:  Robert D Kendig; Fumitake Kai; Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Invest       Date:  2017-04-13       Impact factor: 2.176

2.  YB-1, the E2F pathway, and regulation of tumor cell growth.

Authors:  Annette Lasham; Weini Samuel; Helen Cao; Rachna Patel; Reena Mehta; J Lewis Stern; Glen Reid; Adele G Woolley; Lance D Miller; Michael A Black; Andrew N Shelling; Cristin G Print; Antony W Braithwaite
Journal:  J Natl Cancer Inst       Date:  2011-12-28       Impact factor: 13.506

3.  Cellular senescence and protein degradation: breaking down cancer.

Authors:  Xavier Deschênes-Simard; Frédéric Lessard; Marie-France Gaumont-Leclerc; Nabeel Bardeesy; Gerardo Ferbeyre
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

4.  Characterization of the recombinant adenovirus vector AdYB-1: implications for oncolytic vector development.

Authors:  Gabriel Glockzin; Klaus Mantwill; Karsten Jurchott; Alexandra Bernshausen; Axel Ladhoff; Hans-Dieter Royer; Bernd Gansbacher; Per Sonne Holm
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 5.  Transcription factors that interact with p53 and Mdm2.

Authors:  Kazushi Inoue; Elizabeth A Fry; Donna P Frazier
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

6.  Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy.

Authors:  Y Zhang; S R Reng; L Wang; L Lu; Z H Zhao; Z K Zhang; X D Feng; X D Ding; J Wang; G Feng; T Z Dai; J Pu; X B Du
Journal:  Med Oncol       Date:  2011-09-11       Impact factor: 3.064

7.  KMT5c modulates adipocyte thermogenesis by regulating Trp53 expression.

Authors:  Qingwen Zhao; Zhe Zhang; Weiqiong Rong; Weiwei Jin; Linyu Yan; Wenfang Jin; Yingjiang Xu; Xuan Cui; Qi-Qun Tang; Dongning Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

8.  Cold shock domain protein 3 regulates freezing tolerance in Arabidopsis thaliana.

Authors:  Myung-Hee Kim; Kentaro Sasaki; Ryozo Imai
Journal:  J Biol Chem       Date:  2009-06-25       Impact factor: 5.157

9.  Assessing nucleic acid binding activity of four dinoflagellate cold shock domain proteins from Symbiodinium kawagutii and Lingulodinium polyedra.

Authors:  Bahareh Zaheri; David Morse
Journal:  BMC Mol Cell Biol       Date:  2021-05-08

10.  YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression.

Authors:  Joyce Wu; Anna L Stratford; Arezoo Astanehe; Sandra E Dunn
Journal:  Transl Oncogenomics       Date:  2007-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.